More on IONS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $60.36 |
|
|||
| Open | $60.37 | ||||
| 52 Wk High | $62.68 | ||||
| 52 Wk Low | $19.59 | ||||
| Day High | $60.99 | ||||
| Day Low | $59.78 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,872,595 | ||||
- H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- JPMorgan Reiterates Overweight Rating on Ionis Pharmaceuticals (IONS)
- Alnylam stock drops on rival heart trial: Why analysts see core business safe
- Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- Ionis to present olezarsen and ION775 data at ESC Congress 2026
- Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026
- BMO Capital Starts Ionis Pharmaceuticals (IONS) at Market Perform
- Ionis Pharmaceuticals (IONS) PT Raised to $76 at JPMorgan
- Form 4 IONIS PHARMACEUTICALS For: Jul 30 Filed by: Hayden Michael R
- Form S-8 IONIS PHARMACEUTICALS
Entities mentioned with ions
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
